Hydroxyalkyl-1,2,4-triazolidine-3,5-diones and a process for their production
AssigneeBayer Aktiengesellschaft
InventorsHenning Giesecke, Rudolf Merten, Ludwig Rottmaier
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsHenning Giesecke, Rudolf Merten, Ludwig Rottmaier
Estimating the term…
New hydroxyalkyl-1,2,4-triazolidine-3,5-diones corresponding to the general Formula I ##STR1## in which R.sup.1 represents a monofunctional to pentafunctional organic radical, optionally substituted and/or optionally interrupted by hetero atoms or hetero atom groups, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are the same or different and represent hydrogen, an aliphatic C.sub.1 -C.sub.1 O-radical, a cycloaliphatic C.sub.4 -C.sub.8 radical or an araliphatic C.sub.7 -C.sub.17 -radical, said radicals are optionally substituted by halogen, an aromatic C.sub.6 -C.sub.16 -radical or an aromatic C.sub.6 -C.sub.16 -radical substituted by halogen, C.sub.1 -C.sub.4 -alkyl or C.sub.1 -C.sub.4 -alkoxy, a and b are the same or different and represent a number of from 1 to 30, and n=a number of from 1 to 5. The new compounds are obtained by oxalkylation reaction using 1,2,4-triazolidine-3,5-diones of Formula I as starting materials in which a and b represent the number 0.
A hydroxyalkyl- 1,2,4-triazolidine-3,5-dione of the formula ##STR20## wherein R.sup.1 is selected from the group consisting of ##STR21## R.sup.2, R.sup.3 and R.sup.4 are hydrogen;
Dependencies are inferred from the claim text.